|
1
|
An inventory for measuring depression.
|
Arch Gen Psychiatry
|
1961
|
84.61
|
|
2
|
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.
|
Arch Gen Psychiatry
|
1999
|
5.40
|
|
3
|
Fish consumption and major depression.
|
Lancet
|
1998
|
3.42
|
|
4
|
Bipolar disorder.
|
N Engl J Med
|
2004
|
2.75
|
|
5
|
Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity.
|
Am J Clin Nutr
|
2006
|
2.63
|
|
6
|
A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
|
J Clin Psychiatry
|
2007
|
2.38
|
|
7
|
Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.
|
Br J Psychiatry
|
2006
|
2.00
|
|
8
|
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder.
|
Am J Psychiatry
|
2002
|
1.98
|
|
9
|
The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil.
|
Am J Clin Nutr
|
1996
|
1.86
|
|
10
|
Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.
|
Eur Neuropsychopharmacol
|
2003
|
1.84
|
|
11
|
A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.
|
Arch Gen Psychiatry
|
2002
|
1.82
|
|
12
|
Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
|
J Clin Psychiatry
|
2011
|
1.81
|
|
13
|
Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial.
|
Br J Psychiatry
|
2007
|
1.75
|
|
14
|
Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients.
|
Biol Psychiatry
|
1998
|
1.73
|
|
15
|
Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder.
|
Biol Psychiatry
|
2006
|
1.67
|
|
16
|
Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
|
J Clin Psychiatry
|
2008
|
1.51
|
|
17
|
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
|
Lipids Health Dis
|
2007
|
1.51
|
|
18
|
A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.
|
Am J Psychiatry
|
2003
|
1.46
|
|
19
|
Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression.
|
Lipids
|
1996
|
1.44
|
|
20
|
Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.
|
Am J Psychiatry
|
2006
|
1.43
|
|
21
|
Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis.
|
J Affect Disord
|
2002
|
1.41
|
|
22
|
Cross-national comparisons of seafood consumption and rates of bipolar disorders.
|
Am J Psychiatry
|
2003
|
1.33
|
|
23
|
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.
|
Int J Neuropsychopharmacol
|
2009
|
1.28
|
|
24
|
The efficacy of omega-3 supplementation for major depression: a randomized controlled trial.
|
J Clin Psychiatry
|
2010
|
1.21
|
|
25
|
Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder.
|
Psychiatry Res
|
2008
|
1.17
|
|
26
|
Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography.
|
J Lipid Res
|
2008
|
1.14
|
|
27
|
The role of omega-3 fatty acids in mood disorders.
|
Curr Opin Investig Drugs
|
2008
|
1.14
|
|
28
|
Fish consumption, depression, and suicidality in a general population.
|
Arch Gen Psychiatry
|
2001
|
1.13
|
|
29
|
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
|
Biol Psychiatry
|
2006
|
1.13
|
|
30
|
Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses.
|
J Lipid Res
|
2005
|
1.10
|
|
31
|
Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
|
J Affect Disord
|
2008
|
1.07
|
|
32
|
Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.
|
J Clin Psychopharmacol
|
2012
|
1.05
|
|
33
|
Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
|
J Psychiatr Res
|
2011
|
1.00
|
|
34
|
Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial.
|
J Am Coll Nutr
|
2010
|
0.96
|
|
35
|
Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania.
|
Bipolar Disord
|
2007
|
0.96
|
|
36
|
Efficacy of omega-3 fatty acids in mood disorders - a systematic review and metaanalysis.
|
Psychopharmacol Bull
|
2009
|
0.91
|
|
37
|
Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder.
|
Bipolar Disord
|
2010
|
0.88
|
|
38
|
The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study.
|
Eur Arch Psychiatry Clin Neurosci
|
2011
|
0.86
|
|
39
|
Essential fatty acids in health and chronic diseases.
|
Forum Nutr
|
2003
|
0.83
|
|
40
|
Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression.
|
Br J Psychiatry
|
2016
|
0.82
|
|
41
|
Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial.
|
J Clin Psychopharmacol
|
2012
|
0.80
|
|
42
|
Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.
|
J Clin Psychiatry
|
2005
|
0.80
|
|
43
|
Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms.
|
BMC Psychiatry
|
2012
|
0.78
|
|
44
|
Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
|
Prostaglandins Leukot Essent Fatty Acids
|
2006
|
0.78
|